| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.26 | 7e-07 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.22 | 4e-06 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.19 | 8e-06 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.21 | 2e-05 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.12 | 9e-05 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.2 | 0.0002 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.099 | 0.0005 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.099 | 0.002 |